Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

4.065 -0.015 (-0.37%)
Streaming Delayed Price Updated: 11:08 AM EDT, Aug 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
30 31 Next >
Psychedelics Market Could Reach $12B By 2029, Says New Report
A new analysis of the global market for psychedelics performed by Brandessence Market Research shows an expected growth from 2022’s $4.87 billion to an annual valuation of nearly $12 billion before... 
Via Benzinga
Mind Medicine, Seelos Therapeutics Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psychedelics Company Numinus Wellness Consolidates Recent Surge Higher: What's Going On?
Numinus Wellness, Inc (OTC: NUMIF) was consolidating about 2% lower on Wednesday after surging over 30% on Tuesday. 
Via Benzinga
Psychedelic Drug Developer Mindset Pharma Optimistic About 2023 After Key 2022 Funding Collaborations And Patent Allowances
Once considered the realm of ancient civilizations and countercultures, psychedelics have in the past few years been seeing increasing interest.  
Via Benzinga
Psyched: Psychedelics In Davos, Prince Harry In The 90s, Cathie Wood's Latest Moves And More
Psychedelics Take Center Stage In Davos Psychedelics will lead the conversation inside the Davos House of Health for a second year in a row this January. 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 17, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 11, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 10, 2023
 
Via Benzinga
Vistagen Poised To Begin Phase 1 Trial Of A Fast-Acting Antidepressant Nasal Spray In First Quarter Of 2023
In the race to create faster-acting, safer antidepressants, Vistagen (NASDAQ: VTGN) is starting the year strong as it gets ready to launch a Phase 1 Trial of its novel pherine nasal spray for Major... 
Via Benzinga
GH Research, Cybin Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 13, 2023
 
Via Benzinga
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
 
Via Benzinga
Cathie Wood Reacts To Atai's Drastic Stock Plunge After Doomed Clinical Study Results
After atai Life Sciences (NASDAQ: ATAI) shared the results of subsidiary Perception Neuroscience’s Phase 2 trial of R-ketamine compound for TRD, the psyche 
Via Benzinga
ATAI Life Sciences, Cybin Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 5, 2023
 
Via Benzinga
Seelos Therapeutics, Cybin Among Top Psychedelic Movers Of Today
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 2, 2023
 
Via Benzinga
Psychedelic Stock Gainers And Losers From January 9, 2023
 
Via Benzinga
My "Rags-To-Riches" Portfolio For 2023: An Introduction
The performance of cannabis, psychedelic and plant-based food stocks in 2022 were just horrible; is there any way to go but up? 
Via Talk Markets
Psychedelic Stock Gainers And Losers From January 3, 2023
 
Via Benzinga
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
What a year for psychedelics! 
Via Benzinga
6 Largest Psychedelic Drug Stocks Were -20% In December
The Psychedelic Drug Stocks Index, which tracks the six largest psychedelic stocks researching the treatment of mental illnesses based on the use of one or more psychedelic substances, continued to... 
Via Talk Markets
Psychedelic Stock Gainers And Losers From December 29, 2022
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 28, 2022
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 27, 2022
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 30, 2022
 
Via Benzinga
Psychedelic Stock Gainers And Losers From December 26, 2022
 
Via Benzinga
Largest Psychedelic Stocks -7.6% This Week; Now -21.7% This Month
Highlighting the performance of the six stocks in our Psychedelic Drug Stocks Index, which are researching the treatment of mental illnesses using 10 different psychedelic substances. 
Via Talk Markets
Cannabis Category Performances Ranged From +0.5% To -17% Last Week
The 5 categories in the cannabis sector perform quite differently week-to-week and last week was no exception. Below is a summary of each category's performance last week, in descending order, since... 
Via Talk Markets
Psychedelic Stock Gainers And Losers From December 23, 2022
 
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
30 31 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.